I think it’s less “pivoting is hard” and more “we know what’s right and we’re not going to pivot”.

It’s not hard to have smaller R&D teams work on these problems to keep the innovation going, but most executives are out there prioritizing cost cuttings so that the shareholders get the quarterly dopamine boosts on the earnings calls.